CN111978352A - Organic electroluminescent material and device - Google Patents

Organic electroluminescent material and device Download PDF

Info

Publication number
CN111978352A
CN111978352A CN202010435881.5A CN202010435881A CN111978352A CN 111978352 A CN111978352 A CN 111978352A CN 202010435881 A CN202010435881 A CN 202010435881A CN 111978352 A CN111978352 A CN 111978352A
Authority
CN
China
Prior art keywords
compound
group
ring
ligands
ligand
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010435881.5A
Other languages
Chinese (zh)
Inventor
施韦春
皮埃尔-吕克·T·布德罗
伯特·阿莱恩
T·费利塔姆
姬志强
陈小凡
J·费尔德曼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universal Exhibition Co
Original Assignee
Universal Exhibition Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US16/867,014 external-priority patent/US11634445B2/en
Application filed by Universal Exhibition Co filed Critical Universal Exhibition Co
Publication of CN111978352A publication Critical patent/CN111978352A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086Platinum compounds
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/30Coordination compounds
    • H10K85/341Transition metal complexes, e.g. Ru(II)polypyridine complexes
    • H10K85/346Transition metal complexes, e.g. Ru(II)polypyridine complexes comprising platinum
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/40Organosilicon compounds, e.g. TIPS pentacene
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/615Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/615Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
    • H10K85/622Polycyclic condensed aromatic hydrocarbons, e.g. anthracene containing four rings, e.g. pyrene
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/615Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
    • H10K85/624Polycyclic condensed aromatic hydrocarbons, e.g. anthracene containing six or more rings
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/615Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
    • H10K85/626Polycyclic condensed aromatic hydrocarbons, e.g. anthracene containing more than one polycyclic condensed aromatic rings, e.g. bis-anthracene
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/654Aromatic compounds comprising a hetero atom comprising only nitrogen as heteroatom
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6572Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6576Polycyclic condensed heteroaromatic hydrocarbons comprising only sulfur in the heteroaromatic polycondensed ring system, e.g. benzothiophene
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/18Metal complexes
    • C09K2211/185Metal complexes of the platinum group, i.e. Os, Ir, Pt, Ru, Rh or Pd

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Electroluminescent Light Sources (AREA)

Abstract

The present invention relates to electroluminescent materials and devices. Providing a composition comprising formula 1
Figure DDA0002502234860000011
First ligand L ofA

Description

Organic electroluminescent material and device
CROSS-REFERENCE TO RELATED APPLICATIONS
This application claims priority from U.S. provisional application No. 62/850,800 filed 2019, 5/21, 35 u.s.c. § 119(e), the entire content of which is incorporated herein by reference.
Technical Field
The present disclosure relates generally to organometallic compounds and formulations and various uses thereof, including as emitters in devices such as organic light emitting diodes and related electronic devices.
Background
Photovoltaic devices utilizing organic materials are becoming increasingly popular for a variety of reasons. Many of the materials used to make such devices are relatively inexpensive, and therefore organic photovoltaic devices have the potential for cost advantages over inorganic devices. In addition, the inherent properties of organic materials (e.g., their flexibility) may make them more suitable for particular applications, such as fabrication on flexible substrates. Examples of organic optoelectronic devices include organic light emitting diodes/devices (OLEDs), organic phototransistors, organic photovoltaic cells, and organic photodetectors. For OLEDs, organic materials may have performance advantages over conventional materials.
OLEDs utilize organic thin films that emit light when a voltage is applied across the device. OLEDs are becoming an increasingly interesting technology for applications such as flat panel displays, lighting and backlighting.
One application of phosphorescent emissive molecules is in full color displays. Industry standards for such displays require pixels adapted to emit a particular color, known as a "saturated" color. In particular, these standards require saturated red, green, and blue pixels. Alternatively, OLEDs can be designed to emit white light. In conventional liquid crystal displays, an absorptive filter is used to filter the emission from a white backlight to produce red, green, and blue emissions. The same technique can also be used for OLEDs. The white OLED may be a single emission layer (EML) device or a stacked structure. Color can be measured using CIE coordinates well known in the art.
Disclosure of Invention
Transition metal compounds of naphthylene-aryl bidentate ligands having rigid and conjugated moieties are disclosed. Such transition metal complexes are suitable for use as emitter materials in organic electroluminescent devices.
In one aspect, the present disclosure provides a composition comprising formula 1
Figure BDA0002502234840000021
First ligand L ofAA compound of (1); wherein each X is1To X10Is C or N; x in the same ring as N1To X10The maximum number of (a) is three; rAAnd RBEach represents mono-to maximum permissible substitution or no substitution; l isAComplexing with a metal M; each RAAnd RBIndependently hydrogen or a substituent selected from the group consisting of the general substituents defined herein; m may coordinate to other ligands; ligand LAMay be linked to other ligands to form tridentate, tetradentate, pentadentate or hexadentate ligands; and any two substituents may be joined or fused together to form a ring.
In another aspect, the present disclosure provides a formulation of a compound of the present disclosure.
In yet another aspect, the present disclosure provides an OLED having an organic layer comprising a compound of the present disclosure.
In yet another aspect, the present disclosure provides a consumer product comprising an OLED having an organic layer comprising a compound of the present disclosure.
Drawings
Fig. 1 shows an organic light emitting device.
Fig. 2 shows an inverted organic light emitting device without a separate electron transport layer.
FIG. 3 shows Photoluminescence (PL) spectra of example compounds I-A34 of the invention taken in 2-methyl THF solution at room temperature.
Detailed Description
A. Term(s) for
Unless otherwise specified, the following terms as used herein are defined as follows:
as used herein, the term "organic" includes polymeric materials and small molecule organic materials that may be used to fabricate organic optoelectronic devices. "Small molecule" refers to any organic material that is not a polymer, and "small molecules" may actually be quite large. In some cases, the small molecule may include a repeat unit. For example, the use of long chain alkyl groups as substituents does not remove a molecule from the "small molecule" class. Small molecules can also be incorporated into polymers, for example as pendant groups on the polymer backbone or as part of the backbone. Small molecules can also serve as the core moiety of a dendrimer, which consists of a series of chemical shells built on the core moiety. The core moiety of the dendrimer may be a fluorescent or phosphorescent small molecule emitter. Dendrimers can be "small molecules," and all dendrimers currently used in the OLED art are considered small molecules.
As used herein, "top" means furthest from the substrate, and "bottom" means closest to the substrate. Where a first layer is described as being "disposed" over "a second layer, the first layer is disposed farther from the substrate. Other layers may be present between the first and second layers, unless it is specified that the first layer is "in contact with" the second layer. For example, a cathode may be described as "disposed over" an anode even though various organic layers are present between the cathode and the anode.
As used herein, "solution processable" means capable of being dissolved, dispersed or transported in and/or deposited from a liquid medium in the form of a solution or suspension.
A ligand may be referred to as "photoactive" when it is believed that the ligand contributes directly to the photoactive properties of the emissive material. A ligand may be referred to as "ancillary" when it is believed that the ligand does not contribute to the photoactive properties of the emissive material, but the ancillary ligand may alter the properties of the photoactive ligand.
As used herein, and as will be generally understood by those skilled in the art, if the first energy level is closer to the vacuum energy level, the first "Highest Occupied Molecular Orbital" (HOMO) or "Lowest Unoccupied Molecular Orbital" (LUMO) energy level is "greater than" or "higher than" the second HOMO or LUMO energy level. Since Ionization Potential (IP) is measured as negative energy relative to vacuum level, a higher HOMO level corresponds to an IP with a smaller absolute value (less negative IP). Similarly, a higher LUMO energy level corresponds to an Electron Affinity (EA) with a smaller absolute value (a less negative EA). On a conventional energy level diagram with vacuum levels at the top, the LUMO energy level of a material is higher than the HOMO energy level of the same material. The "higher" HOMO or LUMO energy level appears closer to the top of this figure than the "lower" HOMO or LUMO energy level.
As used herein, and as will be generally understood by those skilled in the art, a first work function is "greater than" or "higher than" a second work function if the first work function has a higher absolute value. Since the work function is typically measured as negative relative to the vacuum level, this means that the "higher" work function is more negative (more negative). On a conventional energy level diagram with vacuum level at the top, the "higher" work function is illustrated as being farther from the vacuum level in the downward direction. Thus, the definitions of HOMO and LUMO energy levels follow a different rule than work functions.
The terms "halo," "halogen," and "halo" are used interchangeably and refer to fluorine, chlorine, bromine, and iodine.
The term "acyl" refers to a substituted carbonyl group (C (O) -Rs)。
The term "ester" refers to a substituted oxycarbonyl group (-O-C (O) -R)sor-C (O) -O-Rs) A group.
The term "ether" means-ORsA group.
The terms "thio" or "thioether" are used interchangeably and refer to-SRsA group.
The term "sulfinyl" refers to-S (O) -RsA group.
The term "sulfonyl" refers to-SO2-RsA group.
The term "phosphino" refers to-P (R)s)3Group, wherein each RsMay be the same or different.
The term "silyl" refers to-Si (R)s)3Group, wherein each RsMay be the same or different.
The term "oxyboronyl" refers to-B (R)s)2Group or Lewis adduct thereof (R) -B (R)s)3Group, wherein RsMay be the same or different.
In each of the above, RsMay be hydrogen or a substituent selected from the group consisting of: deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, aralkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, and combinations thereof. Preferred RsSelected from the group consisting of: alkyl, cycloalkyl, aryl, heteroaryl, and combinations thereof.
The term "alkyl" refers to and includes straight and branched chain alkyl groups. Preferred alkyl groups are those containing from one to fifteen carbon atoms and include methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1-dimethylpropyl, 1, 2-dimethylpropyl, 2-dimethylpropyl, and the like. In addition, the alkyl group may be optionally substituted.
The term "cycloalkyl" refers to and includes monocyclic, polycyclic and spiroalkyl groups. Preferred cycloalkyl groups are those containing 3 to 12 ring carbon atoms and include cyclopropyl, cyclopentyl, cyclohexyl, bicyclo [3.1.1] heptyl, spiro [4.5] decyl, spiro [5.5] undecyl, adamantyl, and the like. In addition, the cycloalkyl group may be optionally substituted.
The term "heteroalkyl" or "heterocycloalkyl" refers to an alkyl or cycloalkyl group, respectively, having at least one carbon atom replaced with a heteroatom. Optionally, the at least one heteroatom is selected from O, S, N, P, B, Si and Se, preferably O, S or N. In addition, heteroalkyl or heterocycloalkyl groups may be optionally substituted.
The term "alkenyl" refers to and includes straight and branched chain alkenyl groups. An alkenyl group is essentially an alkyl group that includes at least one carbon-carbon double bond in the alkyl chain. Cycloalkenyl is essentially cycloalkyl that includes at least one carbon-carbon double bond in the cycloalkyl ring. The term "heteroalkenyl" as used herein refers to an alkenyl group having at least one carbon atom replaced with a heteroatom. Optionally, the at least one heteroatom is selected from O, S, N, P, B, Si and Se, preferably O, S or N. Preferred alkenyl, cycloalkenyl or heteroalkenyl groups are those containing from two to fifteen carbon atoms. In addition, the alkenyl, cycloalkenyl or heteroalkenyl groups may be optionally substituted.
The term "alkynyl" refers to and includes straight and branched chain alkynyl groups. Alkynyl is essentially an alkyl group comprising at least one carbon-carbon triple bond in the alkyl chain. Preferred alkynyl groups are those containing from two to fifteen carbon atoms. In addition, alkynyl groups may be optionally substituted.
The terms "aralkyl" or "arylalkyl" are used interchangeably and refer to an alkyl group substituted with an aryl group. In addition, the aralkyl group may be optionally substituted.
The term "heterocyclyl" refers to and includes both aromatic and non-aromatic cyclic groups containing at least one heteroatom. Optionally, the at least one heteroatom is selected from O, S, N, P, B, Si and Se, preferably O, S or N. Aromatic heterocyclic groups may be used interchangeably with heteroaryl groups. Preferred non-aromatic heterocyclic groups are heterocyclic groups containing 3 to 7 ring atoms including at least one heteroatom and include cyclic amines such as morpholinyl, piperidinyl, pyrrolidinyl and the like, and cyclic ethers/thioethers such as tetrahydrofuran, tetrahydropyran, tetrahydrothiophene and the like. In addition, the heterocyclic group may be optionally substituted.
The term "aryl" refers to and includes monocyclic aromatic hydrocarbon radicals and polycyclic aromatic ring systems. Polycyclic rings can have two or more rings in which two carbons are common to two adjoining rings (the rings are "fused"), wherein at least one of the rings is an aromatic hydrocarbyl, e.g., the other rings can be cycloalkyls, cycloalkenyls, aryls, heterocyclics, and/or heteroaryls. Preferred aryl groups are those containing from six to thirty carbon atoms, preferably from six to twenty carbon atoms, more preferably from six to twelve carbon atoms.Especially preferred are aryl groups having six carbons, ten carbons, or twelve carbons. Suitable aryl groups include phenyl, biphenyl, terphenyl, triphenylene, tetraphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene, perylene,
Figure BDA0002502234840000051
Perylene and azulene, preferably phenyl, biphenyl, terphenyl, triphenylene, fluorene and naphthalene. In addition, the aryl group may be optionally substituted.
The term "heteroaryl" refers to and includes monocyclic aromatic groups and polycyclic aromatic ring systems that include at least one heteroatom. Heteroatoms include, but are not limited to O, S, N, P, B, Si and Se. In many cases O, S or N are preferred heteroatoms. Monocyclic heteroaromatic systems are preferably monocyclic with 5 or 6 ring atoms, and rings may have one to six heteroatoms. A heteropolycyclic system can have two or more rings in which two atoms are common to two adjoining rings (the rings are "fused"), wherein at least one of the rings is heteroaryl, e.g., the other rings can be cycloalkyls, cycloalkenyls, aryls, heterocycles and/or heteroaryls. The heterocyclic aromatic ring system may have one to six heteroatoms per ring of the polycyclic aromatic ring system. Preferred heteroaryl groups are those containing from three to thirty carbon atoms, preferably from three to twenty carbon atoms, more preferably from three to twelve carbon atoms. Suitable heteroaryl groups include dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridylindole, pyrrolobipyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, oxatriazole, dioxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole, indolizine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, phenoxazine, benzofuropyridine, furobipyridine, benzothienopyridine, thienobipyridine, benzothienopyridine, and selenenopyridine, preferably dibenzothiophene, and benzothiophene, Dibenzofurans, dibenzoselenophenes, carbazoles, indolocarbazoles, imidazoles, pyridines, triazines, benzimidazoles, 1, 2-azaborines, 1, 3-azaborines, 1, 4-azaborines, borazines, and aza analogs thereof. In addition, the heteroaryl group may be optionally substituted.
Of the aryl and heteroaryl groups listed above, triphenylene, naphthalene, anthracene, dibenzothiophene, dibenzofuran, dibenzoselenophene, carbazole, indolocarbazole, imidazole, pyridine, pyrazine, pyrimidine, triazine, and benzimidazole are of particular interest, as well as their respective corresponding aza analogues.
The terms alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aralkyl, heterocyclyl, aryl, and heteroaryl, as used herein, are independently unsubstituted or independently substituted with one or more general substituents.
In many cases, typical substituents are selected from the group consisting of: deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, aralkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, thio, sulfinyl, sulfonyl, phosphino, borinyl, and combinations thereof.
In some cases, preferred general substituents are selected from the group consisting of: deuterium, fluorine, alkyl, cycloalkyl, heteroalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile, thio, oxyboronyl, and combinations thereof.
In some cases, more preferred general substituents are selected from the group consisting of: deuterium, fluorine, alkyl, cycloalkyl, alkoxy, aryloxy, amino, silyl, oxyboronyl, aryl, heteroaryl, thio, and combinations thereof.
In other cases, most preferred general substituents are selected from the group consisting of: deuterium, fluoro, alkyl, cycloalkyl, aryl, heteroaryl, and combinations thereof.
The terms "substituted" and "substitution"means that a substituent other than H is bonded to the relevant position, such as carbon or nitrogen. For example, when R is1When representing a single substitution, then one R1Must not be H (i.e., substituted). Similarly, when R is1When representing disubstituted, then two R1Must not be H. Similarly, when R is1When represents zero or no substitution, R1For example, it may be hydrogen of available valency for the ring atoms, such as the carbon atom of benzene and the nitrogen atom of pyrrole, or it may be hydrogen of only zero for ring atoms having fully saturated valency, such as the nitrogen atom of pyridine. The maximum number of substitutions possible in a ring structure will depend on the total number of available valences in the ring atoms.
As used herein, "a combination thereof" means that one or more members of the applicable list are combined to form a known or chemically stable arrangement that one of ordinary skill in the art can envision from the applicable list. For example, alkyl and deuterium can be combined to form a partially or fully deuterated alkyl; halogen and alkyl may combine to form haloalkyl substituents; and halogen, alkyl, and aryl groups may be combined to form haloaralkyl groups. In one example, the term substituted includes combinations of two to four of the listed groups. In another example, the term substitution includes a combination of two to three groups. In yet another example, the term substitution includes a combination of two groups. Preferred combinations of substituents are those containing up to fifty atoms other than hydrogen or deuterium, or those containing up to forty atoms other than hydrogen or deuterium, or those containing up to thirty atoms other than hydrogen or deuterium. In many cases, a preferred combination of substituents will include up to twenty atoms that are not hydrogen or deuterium.
The term "aza" in the fragment described herein, i.e., aza-dibenzofuran, aza-dibenzothiophene, etc., means that one or more of the C-H groups in the corresponding aromatic ring can be replaced by a nitrogen atom, for example and without any limitation, azatriphenylene encompasses dibenzo [ f, H ] quinoxaline and dibenzo [ f, H ] quinoline. Other nitrogen analogs of the aza-derivatives described above can be readily envisioned by one of ordinary skill in the art, and all such analogs are intended to be encompassed by the term as set forth herein.
As used herein, "deuterium" refers to an isotope of hydrogen. Deuterated compounds can be readily prepared using methods known in the art. For example, U.S. patent No. 8,557,400, patent publication No. WO 2006/095951, and U.S. patent application publication No. US 2011/0037057 (which are incorporated herein by reference in their entirety) describe the preparation of deuterium substituted organometallic complexes. With further reference to \37154min (Ming Yan) et al, Tetrahedron (Tetrahedron)2015,71,1425-30 and azrote (Atzrodt) et al, german applied chemistry (angelw. chem. int. ed.) (review) 2007,46,7744-65, which are incorporated by reference in their entirety, describe efficient routes for deuteration of methylene hydrogens in benzylamines and replacement of aromatic ring hydrogens with deuterium, respectively.
It is understood that when a molecular fragment is described as a substituent or otherwise attached to another moiety, its name can be written as if it were a fragment (e.g., phenyl, phenylene, naphthyl, dibenzofuranyl) or as if it were an entire molecule (e.g., benzene, naphthalene, dibenzofuran). As used herein, these different named substituents or the manner of linking the fragments are considered equivalent.
In some cases, a pair of adjacent substituents may optionally join or be fused to form a ring. Preferred rings are five-, six-or seven-membered carbocyclic or heterocyclic rings, including both cases where a portion of the ring formed by the pair of substituents is saturated and where a portion of the ring formed by the pair of substituents is unsaturated. As used herein, "adjacent" means that the two substituents involved can be on the same ring next to each other, or on two adjacent rings having two nearest available substitutable positions (e.g., the 2, 2' positions in biphenyl or the 1, 8 positions in naphthalene), so long as they can form a stable fused ring system.
B. Compounds of the present disclosure
In one aspect, the present disclosure provides a composition comprising formula 1
Figure BDA0002502234840000071
First ligand L ofAA compound of (1); wherein each X is1To X10Is C or N; in the same ring as NX in (1)1To X10The maximum number of (a) is three; rAAnd RBEach represents mono-to maximum permissible substitution or no substitution; l isAComplexing with a metal M; each RAAnd RBIndependently hydrogen or a substituent selected from the group consisting of the general substituents defined herein; m may coordinate to other ligands; the ligand LAMay be linked to other ligands to form tridentate, tetradentate, pentadentate or hexadentate ligands; and any two substituents may be joined or fused together to form a ring.
In some embodiments of the compounds, each RAAnd RBIndependently hydrogen or a substituent selected from the group consisting of the preferred general substituents defined herein.
In some embodiments, M is selected from the group consisting of: ru, Os, Ir, Pd, Pt, Cu, Au and Cu. In some embodiments, M is Pt. In embodiments where M is Pt, the first ligand LAMay be joined to one or two other ligands to form a tridentate or tetradentate ligand.
In some embodiments, RAAnd RBIs a 5-or 6-membered heterocyclic ring. In some embodiments, RAAnd RBAt least one of which is selected from the group consisting of: pyridine, pyrimidine, triazine, imidazole, pyrazole, triazole and N-heterocyclic carbenes.
In some embodiments, X1To X10Is N. In some embodiments, X3Is N. In some embodiments, X3N and X1To X10The remainder of (a) is C. In some embodiments, each X is1To X10Is C. In some embodiments, two RAThe substituents are joined together to form a six-membered carbocyclic or heterocyclic ring. In some embodiments, two or more RBThe substituents are joined together to form a six-membered carbocyclic or heterocyclic ring or ring.
In some embodiments of the compound, the compound has formula 2
Figure BDA0002502234840000081
Wherein M is Pd or Pt; ring C and ring D are each independently a 5-or 6-membered carbocyclic or heterocyclic ring; z1And Z2Each independently is C or N; w1And W2Each independently is C or N; rCAnd RDEach independently represents mono-to maximum permissible substitution or no substitution; l is1、L2And L3Each independently is 1 atom or 2 atom linker, or a direct bond; m, n and p are each independently 0 or 1; m + n + p is 2 or 3; each RCAnd RDIndependently hydrogen or a substituent selected from the group consisting of the general substituents defined herein; and any two substituents may be joined or fused together to form a ring. In some embodiments, each R isCAnd RDIndependently hydrogen or a substituent selected from the group consisting of the preferred general substituents defined herein. In some embodiments, p is 0, and L1And L2Each independently selected from the group consisting of: direct bond, O, S, CRR ', SiRR', BR, and NR; and each R and R' is independently hydrogen or a substituent selected from the group consisting of the general substituents defined herein. In some embodiments, each R and R' is independently hydrogen or a substituent selected from the group consisting of the preferred general substituents defined herein.
In some embodiments of the compound, the compound is selected from the group consisting of:
Figure BDA0002502234840000091
Figure BDA0002502234840000101
Figure BDA0002502234840000111
Figure BDA0002502234840000121
wherein A is1To A10Each independently is C or N, such that the maximum number of N atoms in the same ring is 3; x11To X14And X1To X10Have the same definition; rEAnd RFAnd RCAnd RDHave the same definition; l is4Represents a linker; rXAnd RYEach independently selected from the group consisting of: alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, aryl, heteroaryl, and combinations thereof; and any two substituents may be joined or fused together to form a ring.
In some embodiments of the compound, the compound is selected from the group consisting of:
Figure BDA0002502234840000122
Figure BDA0002502234840000131
Figure BDA0002502234840000141
Figure BDA0002502234840000151
Figure BDA0002502234840000161
Figure BDA0002502234840000171
wherein I is an integer from 1 to 2000, and R for each of formulas I to LVIII1、R2、R3、R4、Y1And Y2The definition is as follows:
Figure BDA0002502234840000172
Figure BDA0002502234840000181
Figure BDA0002502234840000191
Figure BDA0002502234840000201
Figure BDA0002502234840000211
Figure BDA0002502234840000221
Figure BDA0002502234840000231
Figure BDA0002502234840000241
Figure BDA0002502234840000251
Figure BDA0002502234840000261
Figure BDA0002502234840000271
Figure BDA0002502234840000281
Figure BDA0002502234840000291
Figure BDA0002502234840000301
Figure BDA0002502234840000311
Figure BDA0002502234840000321
Figure BDA0002502234840000331
Figure BDA0002502234840000341
Figure BDA0002502234840000351
Figure BDA0002502234840000361
Figure BDA0002502234840000371
Figure BDA0002502234840000381
Figure BDA0002502234840000391
wherein R isA1To RA53Has the following structure:
Figure BDA0002502234840000392
Figure BDA0002502234840000393
Figure BDA0002502234840000401
Figure BDA0002502234840000402
and is
Wherein R isB1To RB46Has the following structure:
Figure BDA0002502234840000403
Figure BDA0002502234840000404
Figure BDA0002502234840000405
and is
Wherein R isC1To RC292Has the following structure:
Figure BDA0002502234840000411
Figure BDA0002502234840000412
Figure BDA0002502234840000421
Figure BDA0002502234840000431
Figure BDA0002502234840000441
Figure BDA0002502234840000451
Figure BDA0002502234840000461
Figure BDA0002502234840000471
in some embodiments of the compound, the compound is selected from the group consisting of:
Figure BDA0002502234840000472
Figure BDA0002502234840000481
Figure BDA0002502234840000491
Figure BDA0002502234840000501
Figure BDA0002502234840000511
C. OLEDs and devices of the present disclosure
In another aspect, the present disclosure also provides an OLED device comprising a first organic layer comprising a compound as disclosed in the above compounds section of the present disclosure.
In some embodiments, the OLED comprises an anode, a cathode, and a second electrode disposed on the anodeAn organic layer between the anode and the cathode. The organic layer may comprise a compound comprising formula 1
Figure BDA0002502234840000512
First ligand L ofA(ii) a Wherein each X is1To X10Is C or N; x in the same ring as N1To X10The maximum number of (a) is three; rAAnd RBEach represents mono-to maximum permissible substitution or no substitution; l isAComplexing with a metal M; each RAAnd RBIndependently hydrogen or a substituent selected from the group consisting of: deuterium, halo, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, aralkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, thio, sulfinyl, sulfonyl, phosphino, borinyl, and combinations thereof; m may coordinate to other ligands; the ligand LAMay be linked to other ligands to form tridentate, tetradentate, pentadentate or hexadentate ligands; and any two substituents may be joined or fused together to form a ring.
In some embodiments, the organic layer may be an emissive layer and the compound as described herein may be an emissive dopant or a non-emissive dopant.
In some embodiments, the organic layer may further comprise a host, wherein the host comprises a triphenylene comprising a benzo-fused thiophene or a benzo-fused furan, wherein any substituent in the host is a non-fused substituent independently selected from the group consisting of: cnH2n+1、OCnH2n+1、OAr1、N(CnH2n+1)2、N(Ar1)(Ar2)、CH=CH-CnH2n+1、C≡CCnH2n+1、Ar1、Ar1-Ar2、CnH2n-Ar1Or no substituent, wherein n is 1 to 10; and wherein Ar1And Ar2Independently selected from the group consisting of: benzene and its derivativesBiphenyl, naphthalene, triphenylene, carbazole and heteroaromatic analogs thereof.
In some embodiments, the organic layer may further comprise a host, wherein the host comprises at least one chemical group selected from the group consisting of: triphenylene, carbazole, indolocarbazole, dibenzothiophene, dibenzofuran, dibenzoselenophene, 5, 9-dioxa-13 b-boronaphtho [3,2,1-de ] anthracene, aza-triphenylene, aza-carbazole, aza-indolocarbazole, aza-dibenzothiophene, aza-dibenzofuran, aza-dibenzoselenophene, and aza- (5, 9-dioxa-13 b-boronaphtho [3,2,1-de ] anthracene).
In some embodiments, the subject may be selected from the group of subjects consisting of:
Figure BDA0002502234840000521
Figure BDA0002502234840000531
Figure BDA0002502234840000541
Figure BDA0002502234840000542
and combinations thereof.
In some embodiments, the organic layer may further comprise a host, wherein the host comprises a metal complex.
In some embodiments, a compound as described herein may be a sensitizer; wherein the device may further comprise a receptor; and wherein the receptor may be selected from the group consisting of: fluorescent emitters, delayed fluorescent emitters, and combinations thereof.
In yet another aspect, the OLEDs of the present disclosure can further comprise an emissive region comprising a compound as disclosed in the above compounds section of the present disclosure.
In some casesIn embodiments, the emissive region can comprise a compound comprising formula 1
Figure BDA0002502234840000543
Ligand L ofA(ii) a Wherein each X is1To X10Is C or N; x in the same ring as N1To X10The maximum number of (a) is three; rAAnd RBEach represents mono-to maximum permissible substitution or no substitution; l isAComplexing with a metal M; each RAAnd RBIndependently hydrogen or a substituent selected from the group consisting of the general substituents defined herein; m may coordinate to other ligands; the ligand LAMay be linked to other ligands to form tridentate, tetradentate, pentadentate or hexadentate ligands; and any two substituents may be joined or fused together to form a ring.
In yet another aspect, the present disclosure also provides a consumer product comprising an Organic Light Emitting Device (OLED) having an anode; a cathode; and an organic layer disposed between the anode and the cathode, wherein the organic layer can comprise a compound as disclosed in the above compounds section of the present disclosure.
In some embodiments, the consumer product comprises an OLED having an anode; a cathode; and an organic layer disposed between the anode and the cathode, wherein the organic layer may comprise a compound comprising formula 1
Figure BDA0002502234840000551
First ligand L ofA(ii) a Wherein each X is1To X10Is C or N; x in the same ring as N1To X10The maximum number of (a) is three; rAAnd RBEach represents mono-to maximum permissible substitution or no substitution; l isAComplexing with a metal M; each RAAnd RBIndependently hydrogen or a substituent selected from the group consisting of the general substituents defined herein; m may coordinate to other ligands; the ligand LACan be linked with other ligands toForming a tridentate, tetradentate, pentadentate or hexadentate ligand; and any two substituents may be joined or fused together to form a ring.
In some embodiments, the consumer product may be one of the following: a flat panel display, a computer monitor, a medical monitor, a television, a billboard, a light for interior or exterior lighting and/or signaling, a heads-up display, a fully or partially transparent display, a flexible display, a laser printer, a telephone, a cellular telephone, a tablet, a phablet, a Personal Digital Assistant (PDA), a wearable device, a laptop computer, a digital camera, a video camera, a viewfinder, a microdisplay at a diagonal of less than 2 inches, a 3-D display, a virtual reality or augmented reality display, a vehicle, a video wall containing multiple displays tiled together, a theater or stadium screen, a phototherapy device, and a sign.
Generally, an OLED comprises at least one organic layer disposed between and electrically connected to an anode and a cathode. When current is applied, the anode injects holes and the cathode injects electrons into the organic layer. The injected holes and electrons each migrate toward the oppositely charged electrode. When an electron and a hole are located on the same molecule, an "exciton," which is a localized electron-hole pair with an excited energy state, is formed. When the exciton relaxes by a light emission mechanism, light is emitted. In some cases, the exciton may be localized on an excimer (eximer) or an exciplex. Non-radiative mechanisms (such as thermal relaxation) may also occur, but are generally considered undesirable.
Several OLED materials and configurations are described in U.S. patent nos. 5,844,363, 6,303,238, and 5,707,745, which are incorporated herein by reference in their entirety.
The initial OLEDs used emissive molecules that emit light from a singlet state ("fluorescence"), as disclosed, for example, in U.S. patent No. 4,769,292, which is incorporated by reference in its entirety. Fluorescence emission typically occurs in a time frame of less than 10 nanoseconds.
More recently, OLEDs having emissive materials that emit light from the triplet state ("phosphorescence") have been demonstrated. Baldo et al, "high efficiency Phosphorescent Emission from Organic Electroluminescent Devices" (Nature), 395, 151-154,1998 ("Baldo-I"); and baldo et al, "Very high-efficiency green organic light-emitting devices based on electrophosphorescence (Very high-efficiency green organic light-emitting devices-based on electrophosphorescence)", applied physical promo (appl. phys. lett.), volume 75, stages 3,4-6 (1999) ("baldo-II"), which are incorporated by reference in their entirety. Phosphorescence is described in more detail in U.S. Pat. No. 7,279,704, columns 5-6, which is incorporated by reference.
Fig. 1 shows an organic light emitting device 100. The figures are not necessarily to scale. Device 100 can include substrate 110, anode 115, hole injection layer 120, hole transport layer 125, electron blocking layer 130, emissive layer 135, hole blocking layer 140, electron transport layer 145, electron injection layer 150, protective layer 155, cathode 160, and blocking layer 170. Cathode 160 is a composite cathode having a first conductive layer 162 and a second conductive layer 164. The device 100 may be fabricated by depositing the layers in sequence. The nature and function of these various layers and example materials are described in more detail in U.S. Pat. No. 7,279,704, columns 6-10, which is incorporated by reference.
More instances of each of these layers are available. For example, a flexible and transparent substrate-anode combination is disclosed in U.S. Pat. No. 5,844,363, which is incorporated by reference in its entirety. An example of a p-doped hole transport layer is doped with F at a molar ratio of 50:14TCNQ m-MTDATA as disclosed in U.S. patent application publication No. 2003/0230980, which is incorporated by reference in its entirety. Examples of luminescent and host materials are disclosed in U.S. Pat. No. 6,303,238 to Thompson et al, which is incorporated by reference in its entirety. An example of an n-doped electron transport layer is BPhen doped with Li at a molar ratio of 1:1, as disclosed in U.S. patent application publication No. 2003/0230980, which is incorporated by reference in its entirety. U.S. patent No. 5,703 incorporated by reference in its entirety,436 and 5,707,745 disclose examples of cathodes comprising composite cathodes having a thin layer of metal (e.g., Mg: Ag) with an overlying transparent, conductive, sputter-deposited ITO layer. The theory and use of barrier layers is described in more detail in U.S. patent No. 6,097,147 and U.S. patent application publication No. 2003/0230980, which are incorporated by reference in their entirety. Examples of injection layers are provided in U.S. patent application publication No. 2004/0174116, which is incorporated by reference in its entirety. A description of the protective layer may be found in U.S. patent application publication No. 2004/0174116, which is incorporated by reference in its entirety.
Fig. 2 shows an inverted OLED 200. The device includes a substrate 210, a cathode 215, an emissive layer 220, a hole transport layer 225, and an anode 230. The device 200 may be fabricated by depositing the layers in sequence. Because the most common OLED configuration has a cathode disposed above an anode, and device 200 has a cathode 215 disposed below an anode 230, device 200 may be referred to as an "inverted" OLED. Materials similar to those described with respect to device 100 may be used in corresponding layers of device 200. Fig. 2 provides one example of how some layers may be omitted from the structure of device 100.
The simple layered structure illustrated in fig. 1 and 2 is provided by way of non-limiting example, and it is to be understood that embodiments of the present disclosure may be used in conjunction with various other structures. The specific materials and structures described are exemplary in nature, and other materials and structures may be used. Functional OLEDs may be obtained by combining the various layers described in different ways, or the layers may be omitted entirely based on design, performance, and cost factors. Other layers not specifically described may also be included. Materials other than those specifically described may be used. Although many of the examples provided herein describe the various layers as comprising a single material, it is understood that combinations of materials may be used, such as mixtures of hosts and dopants, or more generally, mixtures. Further, the layer may have various sub-layers. The names given to the various layers herein are not intended to be strictly limiting. For example, in device 200, hole transport layer 225 transports holes and injects holes into emissive layer 220, and may be described as a hole transport layer or a hole injection layer. In one embodiment, an OLED may be described as having an "organic layer" disposed between a cathode and an anode. This organic layer may comprise a single layer, or may further comprise multiple layers of different organic materials as described, for example, with respect to fig. 1 and 2.
Structures and materials not specifically described may also be used, such as oleds (pleds) comprising polymeric materials, such as disclosed in U.S. patent No. 5,247,190 to frand (Friend), et al, which is incorporated by reference in its entirety. By way of further example, OLEDs having a single organic layer may be used. The OLEDs may be stacked, for example, as described in U.S. patent No. 5,707,745 to forrister (Forrest) et al, which is incorporated by reference in its entirety. The OLED structure may deviate from the simple layered structure illustrated in fig. 1 and 2. For example, the substrate may include an angled reflective surface to improve out-coupling (out-coupling), such as a mesa structure as described in U.S. Pat. No. 6,091,195 to Foster et al, and/or a pit structure as described in U.S. Pat. No. 5,834,893 to Boolean (Bulovic) et al, which are incorporated by reference in their entirety.
Any of the layers of the various embodiments may be deposited by any suitable method, unless otherwise specified. For organic layers, preferred methods include thermal evaporation, ink jetting (as described in U.S. Pat. Nos. 6,013,982 and 6,087,196, both incorporated by reference in their entirety), organic vapor deposition (OVPD) (as described in U.S. Pat. No. 6,337,102 to Foster et al, both incorporated by reference in their entirety), and deposition by Organic Vapor Jet Printing (OVJP) (as described in U.S. Pat. No. 7,431,968, incorporated by reference in its entirety). Other suitable deposition methods include spin coating and other solution-based processes. The solution-based process is preferably carried out in a nitrogen or inert atmosphere. For other layers, a preferred method includes thermal evaporation. Preferred patterning methods include deposition through a mask, cold welding (as described in U.S. Pat. nos. 6,294,398 and 6,468,819, which are incorporated by reference in their entirety), and patterning associated with some of the deposition methods such as inkjet and Organic Vapor Jet Printing (OVJP). Other methods may also be used. The material to be deposited may be modified to suit the particular deposition method. For example, substituents such as alkyl and aryl groups, branched or unbranched, and preferably containing at least 3 carbons, may be used in small molecules to enhance their ability to undergo solution processing. Substituents having 20 carbons or more may be used, and 3 to 20 carbons is a preferred range. A material with an asymmetric structure may have better solution processibility than a material with a symmetric structure because asymmetric materials may have a lower tendency to recrystallize. Dendrimer substituents may be used to enhance the ability of small molecules to undergo solution processing.
Devices fabricated according to embodiments of the present disclosure may further optionally include a barrier layer. One use of barrier layers is to protect the electrodes and organic layers from damage from exposure to hazardous substances in the environment including moisture, vapor, and/or gas. The barrier layer may be deposited on, under or beside the substrate, electrode, or on any other part of the device, including the edge. The barrier layer may comprise a single layer or multiple layers. The barrier layer may be formed by various known chemical vapor deposition techniques and may include compositions having a single phase and compositions having multiple phases. Any suitable material or combination of materials may be used for the barrier layer. The barrier layer may incorporate an inorganic compound or an organic compound or both. Preferred barrier layers comprise a mixture of polymeric and non-polymeric materials as described in U.S. patent No. 7,968,146, PCT patent application nos. PCT/US2007/023098 and PCT/US2009/042829, which are incorporated herein by reference in their entirety. To be considered a "mixture," the aforementioned polymeric and non-polymeric materials that make up the barrier layer should be deposited under the same reaction conditions and/or simultaneously. The weight ratio of polymeric material to non-polymeric material may be in the range of 95:5 to 5: 95. The polymeric material and the non-polymeric material may be produced from the same precursor material. In one example, the mixture of polymeric material and non-polymeric material consists essentially of polymeric silicon and inorganic silicon.
Devices manufactured according to embodiments of the present disclosure may be incorporated into a wide variety of electronic component modules (or units), which may be incorporated into a wide variety of electronic products or intermediate components. Examples of such electronic products or intermediate components include display screens, lighting devices (e.g., discrete light source devices or lighting panels), etc., which may be utilized by end-user product manufacturers. The electronics module may optionally include drive electronics and/or a power source. Devices manufactured in accordance with embodiments of the present disclosure may be incorporated into a wide variety of consumer products having one or more electronic component modules (or units) incorporated therein. A consumer product comprising an OLED comprising a compound of the present disclosure in an organic layer in the OLED is disclosed. The consumer product shall include any kind of product comprising one or more light sources and/or one or more of some type of visual display. Some examples of such consumer products include flat panel displays, curved displays, computer monitors, medical monitors, televisions, billboards, lights for interior or exterior illumination and/or signaling, heads-up displays, fully or partially transparent displays, flexible displays, rollable displays, foldable displays, stretchable displays, laser printers, telephones, cellular telephones, tablet computers, tablet phones, Personal Digital Assistants (PDAs), wearable devices, laptop computers, digital cameras, video cameras, viewfinders, microdisplays (displays less than 2 inches diagonal), 3-D displays, virtual reality or augmented reality displays, vehicles, video walls containing multiple displays tiled together, theater or stadium screens, phototherapy devices, and signs. Various control mechanisms may be used to control devices made in accordance with the present disclosure, including passive matrices and active matrices. Many of the devices are intended to be used in a temperature range that is comfortable for humans, such as 18 ℃ to 30 ℃, and more preferably at room temperature (20-25 ℃), but can be used outside this temperature range (e.g., -40 ℃ to +80 ℃).
More details regarding OLEDs and the definitions described above can be found in U.S. patent No. 7,279,704, which is incorporated herein by reference in its entirety.
The materials and structures described herein may be applied to devices other than OLEDs. For example, other optoelectronic devices such as organic solar cells and organic photodetectors may employ the materials and structures. More generally, organic devices such as organic transistors may employ the materials and structures.
In some embodiments, the OLED has one or more features selected from the group consisting of: flexible, rollable, foldable, stretchable, and bendable. In some embodiments, the OLED is transparent or translucent. In some embodiments, the OLED further comprises a layer comprising carbon nanotubes.
In some embodiments, the OLED further comprises a layer comprising a delayed fluorescence emitter. In some embodiments, the OLED comprises an RGB pixel arrangement or a white plus color filter pixel arrangement. In some embodiments, the OLED is a mobile device, a handheld device, or a wearable device. In some embodiments, the OLED is a display panel having a diagonal of less than 10 inches or an area of less than 50 square inches. In some embodiments, the OLED is a display panel having a diagonal of at least 10 inches or an area of at least 50 square inches. In some embodiments, the OLED is a lighting panel.
In some embodiments, the compound may be an emissive dopant. In some embodiments, the compounds may produce emission via phosphorescence, fluorescence, thermally activated delayed fluorescence (i.e., TADF, also known as E-type delayed fluorescence, see, e.g., U.S. application No. 15/700,352, which is incorporated herein by reference in its entirety), triplet-triplet annihilation, or a combination of these processes. In some embodiments, the emissive dopant may be a racemic mixture, or may be enriched in one enantiomer. In some embodiments, the compounds may be homoleptic (each ligand is the same). In some embodiments, the compounds may be compounded (at least one ligand being different from the others). In some embodiments, when there is more than one ligand that coordinates to the metal, the ligands may all be the same. In some other embodiments, at least one ligand is different from the other ligands. In some embodiments, each ligand may be different from each other. This is also true in embodiments where the ligand that coordinates to the metal can be linked to other ligands that coordinate to the metal to form a tridentate, tetradentate, pentadentate, or hexadentate ligand. Thus, where the coordinating ligands are linked together, in some embodiments all of the ligands may be the same, and in some other embodiments at least one of the linked ligands may be different from the other ligand(s).
In some embodiments, the compounds may be used as phosphorous photosensitizers in OLEDs, where one or more layers in the OLED contain an acceptor in the form of one or more fluorescent and/or delayed fluorescence emitters. In some embodiments, the compounds may be used as a component of an exciplex to be used as a sensitizer. As a phosphosensitizer, a compound must be able to transfer energy to an acceptor and the acceptor will emit energy or further transfer energy to a final emitter. The receptor concentration may range from 0.001% to 100%. The acceptor may be in the same layer as the phosphorous sensitizer or in one or more different layers. In some embodiments, the receptor is a TADF emitter. In some embodiments, the acceptor is a fluorescent emitter. In some embodiments, the emission may be produced by any or all of the sensitizer, the receptor, and the final emitter.
According to another aspect, a formulation comprising a compound described herein is also disclosed.
The OLEDs disclosed herein can be incorporated into one or more of consumer products, electronic component modules, and lighting panels. The organic layer may be an emissive layer, and the compound may be an emissive dopant in some embodiments, while the compound may be a non-emissive dopant in other embodiments.
In yet another aspect of the present invention, a formulation comprising the novel compound disclosed herein is described. The formulation may include one or more of the components disclosed herein selected from the group consisting of: a solvent, a host, a hole injection material, a hole transport material, an electron blocking material, a hole blocking material, and an electron transport material.
The present disclosure encompasses any chemical structure comprising the novel compounds of the present disclosure or monovalent or multivalent variants thereof. In other words, the compounds of the present invention or monovalent or multivalent variants thereof may be part of a larger chemical structure. Such chemical structures may be selected from the group consisting of: monomers, polymers, macromolecules and supramolecules (also known as supramolecules). As used herein, "monovalent variant of a compound" refers to a moiety that is the same as a compound but where one hydrogen has been removed and replaced with a bond to the remainder of the chemical structure. As used herein, "multivalent variants of a compound" refers to moieties that are the same as a compound but where more than one hydrogen has been removed and replaced with one or more bonds to the rest of the chemical structure. In the case of supramolecules, the compounds of the invention may also be incorporated into supramolecular complexes without covalent bonds.
D. Combinations of the compounds of the present disclosure with other materials
Materials described herein as suitable for use in a particular layer in an organic light emitting device can be used in combination with a variety of other materials present in the device. For example, the emissive dopants disclosed herein may be used in conjunction with a wide variety of hosts, transport layers, barrier layers, implant layers, electrodes, and other layers that may be present. The materials described or referenced below are non-limiting examples of materials that can be used in combination with the compounds disclosed herein, and one of ordinary skill in the art can readily review the literature to identify other materials that can be used in combination.
a) Conductive dopant:
the charge transport layer may be doped with a conductivity dopant to substantially change its charge carrier density, which in turn will change its conductivity. The conductivity is increased by the generation of charge carriers in the host material and, depending on the type of dopant, a change in the Fermi level of the semiconductor can also be achieved. The hole transport layer may be doped with a p-type conductivity dopant and an n-type conductivity dopant is used in the electron transport layer.
Non-limiting examples of conductivity dopants that can be used in OLEDs in combination with the materials disclosed herein, along with references disclosing those materials, are exemplified below: EP01617493, EP01968131, EP2020694, EP2684932, US20050139810, US20070160905, US20090167167, US2010288362, WO06081780, WO2009003455, WO2009008277, WO2009011327, WO2014009310, US2007252140, US2015060804, US20150123047 and US 2012146012.
Figure BDA0002502234840000611
b)HIL/HTL:
The hole injection/transport material used in the present disclosure is not particularly limited, and any compound may be used as long as the compound is generally used as the hole injection/transport material. Examples of materials include (but are not limited to): phthalocyanine or porphyrin derivatives; an aromatic amine derivative; indolocarbazole derivatives; a fluorocarbon-containing polymer; a polymer having a conductive dopant; conductive polymers such as PEDOT/PSS; self-assembling monomers derived from compounds such as phosphonic acids and silane derivatives; metal oxide derivatives, e.g. MoOx(ii) a p-type semiconducting organic compounds, such as 1,4,5,8,9, 12-hexaazatriphenylhexacyano-nitrile; a metal complex; and a crosslinkable compound.
Examples of aromatic amine derivatives for use in HILs or HTLs include, but are not limited to, the following general structures:
Figure BDA0002502234840000621
Ar1to Ar9Each of which is selected from: a group consisting of aromatic hydrocarbon cyclic compounds such as: benzene, biphenyl, terphenyl, triphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene,
Figure BDA0002502234840000622
Perylene and azulene; a group consisting of aromatic heterocyclic compounds such as: dibenzothiophene, dibenzofuran, dibenzoselenopheneFuran, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridylindole, pyrrolobipyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, oxatriazole, dioxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole, indolizine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, phenoxazine, benzofuropyridine, furobipyridine, benzothienopyridine, thienobipyridine, benzoselenenopyridine, and selenenopyridine; and a group consisting of 2 to 10 cyclic structural units which are the same type or different types of groups selected from aromatic hydrocarbon ring groups and aromatic heterocyclic groups and are bonded to each other directly or via at least one of an oxygen atom, a nitrogen atom, a sulfur atom, a silicon atom, a phosphorus atom, a boron atom, a chain structural unit and an aliphatic ring group. Each Ar may be unsubstituted or may be substituted with a substituent selected from the group consisting of: deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, aralkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, thio, sulfinyl, sulfonyl, phosphino, and combinations thereof.
In one aspect, Ar1To Ar9Independently selected from the group consisting of:
Figure BDA0002502234840000623
wherein k is an integer from 1 to 20; x101To X108Is C (including CH) or N; z101Is NAr1O or S; ar (Ar)1Having the same groups as defined above.
Examples of metal complexes used in HILs or HTLs include, but are not limited to, the following general formulas:
Figure BDA0002502234840000631
wherein Met is a metal which may have an atomic weight greater than 40; (Y)101-Y102) Is a bidentate ligand, Y101And Y102Independently selected from C, N, O, P and S; l is101Is an ancillary ligand; k' is an integer value from 1 to the maximum number of ligands that can be attached to the metal; and k' + k "is the maximum number of ligands that can be attached to the metal.
In one aspect, (Y)101-Y102) Is a 2-phenylpyridine derivative. In another aspect, (Y)101-Y102) Is a carbene ligand. In another aspect, Met is selected from Ir, Pt, Os and Zn. In another aspect, the metal complex has a structure comparable to Fc+A minimum oxidation potential in solution of less than about 0.6V for/Fc coupling.
Non-limiting examples of HIL and HTL materials that can be used in OLEDs in combination with the materials disclosed herein, along with references disclosing those materials, are exemplified by the following: CN102702075, DE102012005215, EP01624500, EP0169861, EP01806334, EP01930964, EP01972613, EP01997799, EP02011790, EP02055700, EP02055701, EP1725079, EP2085382, EP2660300, EP650955, JP07-073529, JP2005112765, JP2007091, JP 2008021621687, JP2014-009196, KR 201188898, KR20130077473, TW 201139201139402, US06517957, US 2008220158242, US20030162053, US20050123751 751, US 20060282993, US 200602872 14579, US 201181874874, US20070278938, US 20080014014464 091091091, US20080106190, US 200907192605092385, US 12460352009071794392604335200356371798, WO 20120020120020135200353141563543544354435443544354435443544354435443544354435443544354435646, WO 200200352003520035563256325632563256325646, WO 20035200352003520035200435443544354435443544354435443544354435443544354435646, WO 200605646, WO 200605632563256325632563256325646, WO 2002002002002002002002002002002002002002004356325632563256325632563256325632563256325632563256325632563256325632567, WO 2004354435443435632563256325632563256325632563256325632563243544354434354435443544354435443544354435443544354435443541, WO 200200200200200200200200200200200200200200200200200200.
Figure BDA0002502234840000641
Figure BDA0002502234840000651
Figure BDA0002502234840000661
Figure BDA0002502234840000671
Figure BDA0002502234840000681
Figure BDA0002502234840000691
Figure BDA0002502234840000701
c)EBL:
An Electron Blocking Layer (EBL) may be used to reduce the number of electrons and/or excitons that leave the emissive layer. The presence of such a barrier layer in a device may result in substantially higher efficiency and/or longer lifetime compared to a similar device lacking a barrier layer. In addition, blocking layers can be used to limit the emission to the desired area of the OLED. In some embodiments, the EBL material has a higher LUMO (closer to the vacuum level) and/or higher triplet energy than the emitter closest to the EBL interface. In some embodiments, the EBL material has a higher LUMO (closer to the vacuum level) and/or higher triplet energy than one or more of the bodies closest to the EBL interface. In one aspect, the compound used in the EBL contains the same molecule or the same functional group as used in one of the hosts described below.
d) A main body:
the light-emitting layer of the organic EL device of the present disclosure preferably contains at least a metal complex as a light-emitting material, and may contain a host material using the metal complex as a dopant material. Examples of the host material are not particularly limited, and any metal complex or organic compound may be used as long as the triplet energy of the host is larger than that of the dopant. Any host material may be used with any dopant so long as the triplet criteria are met.
Examples of the metal complex used as the host preferably have the following general formula:
Figure BDA0002502234840000702
wherein Met is a metal; (Y)103-Y104) Is a bidentate ligand, Y103And Y104Independently selected from C, N, O, P and S; l is101Is another ligand; k' is an integer value from 1 to the maximum number of ligands that can be attached to the metal; and k' + k "is the maximum number of ligands that can be attached to the metal.
In one aspect, the metal complex is:
Figure BDA0002502234840000703
wherein (O-N) is a bidentate ligand having a metal coordinated to the O and N atoms.
In another aspect, Met is selected from Ir and Pt. In another aspect, (Y)103-Y104) Is a carbene ligand.
In one aspect, the host compound contains at least one selected from the group consisting of: with a fragrance such asGroup consisting of cyclic compounds of aliphatic hydrocarbons: benzene, biphenyl, terphenyl, triphenylene, tetraphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene, perylene,
Figure BDA0002502234840000711
Perylene and azulene; a group consisting of aromatic heterocyclic compounds such as: dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridylindole, pyrrolobipyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, oxatriazole, dioxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole, indolizine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, phenoxazine, benzofuropyridine, furobipyridine, benzothienopyridine, thienobipyridine, benzoselenenopyridine, and selenenopyridine; and a group consisting of 2 to 10 cyclic structural units which are the same type or different types of groups selected from aromatic hydrocarbon ring groups and aromatic heterocyclic groups and are bonded to each other directly or via at least one of an oxygen atom, a nitrogen atom, a sulfur atom, a silicon atom, a phosphorus atom, a boron atom, a chain structural unit and an aliphatic ring group. Each option in each group may be unsubstituted or may be substituted with a substituent selected from the group consisting of: deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, aralkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, thio, sulfinyl, sulfonyl, phosphino, and combinations thereof.
In one aspect, the host compound contains at least one of the following groups in the molecule:
Figure BDA0002502234840000712
Figure BDA0002502234840000721
wherein R is101Selected from the group consisting of: hydrogen, deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, aralkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, thio, sulfinyl, sulfonyl, phosphino, and combinations thereof, and when it is aryl or heteroaryl, it has a similar definition to Ar mentioned above. k is an integer from 0 to 20 or from 1 to 20. X101To X108Independently selected from C (including CH) or N. Z101And Z102Independently selected from NR101O or S.
Non-limiting examples of host materials that can be used in OLEDs in combination with the materials disclosed herein are exemplified below, along with references disclosing those materials: EP2034538, EP2034538A, EP2757608, JP2007254297, KR20100079458, KR20120088644, KR20120129733, KR20130115564, TW201329200, US20030175553, US20050238919, US20060280965, US20090017330, US20090030202, US20090167162, US20090302743, US20090309488, US20100012931, US20100084966, US20100187984, US2010187984, US2012075273, US2012126221, US2013009543, US2013105787, US2013175519, US 001446, US 20148301503, US20140225088, US2014034914, US7154114, WO2001039234, WO 2004093203203203207, WO 2005014545454545452009020090455646, WO 2002012009020120090201902019072201200907220120020190722012002012002016072201200201200201200201607246, WO 20120020120020160722012002016072201200201200201607246, WO 200201200201200201200201200201200201200201200907220020120020120020120020120020120020120090729, WO 200201200201200201200201200201200201200201200201200201200201200201200201200201200201200201200201200200200201200201200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200,
Figure BDA0002502234840000731
Figure BDA0002502234840000741
Figure BDA0002502234840000751
Figure BDA0002502234840000761
Figure BDA0002502234840000771
e) other emitters:
one or more other emitter dopants may be used in combination with the compounds of the present invention. Examples of the other emitter dopant are not particularly limited, and any compound may be used as long as the compound is generally used as an emitter material. Examples of suitable emitter materials include, but are not limited to, compounds that can produce emission via phosphorescence, fluorescence, thermally activated delayed fluorescence (i.e., TADF, also known as E-type delayed fluorescence), triplet-triplet annihilation, or a combination of these processes.
Non-limiting examples of emitter materials that can be used in OLEDs in combination with the materials disclosed herein, along with references disclosing those materials, are exemplified below: CN103694277, CN1696137, EB01238981, EP01239526, EP01961743, EP1239526, EP1244155, EP1642951, EP1647554, EP1841834, EP1841834B, EP2062907, EP2730583, JP 201207440263, JP4478555, KR1020090133652, KR20120032054, KR20130043460, TW201332980, US0669959, US 200100916520, US20010019782, US20020034656, US 20030068568526, US20030072964, US 2003013865657, US 200501787878788, US 20020020020020120044673, US2005123791, US 2006052449 449, US20060008670, US20060065890, US 601696, US 6016016016012006012016016310204659, US 2012002012002012002012002012000477817781979, WO 20020120020120020120020020020020020020004778177819748, US 20120020020004779, WO 200200200201200201200200200200200201200778177819748, US 20020120004779, US 20120020120020120020120020020120020020020004779, US 2002012002002002002002002002002002002002002002002002002002012000477819748, US 200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200779, US 200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200779, US 200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200779, US 20020020020020020020020020020020020020020020020020020020120020120020020020020020020020020020020020020020020020020020020020020020020043979, US 20020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020043979, US 20020020020020020020020020020020020020020020020020020020020020020020020020020020020043979, US 20020020020120020120020020020020020020020020020020020020020020020043979, US 20020020020020020020020020020020020120020120020020020020020020020020020020020020020020020020020020020020020020020020020020120020020020020020020020020020020020020020020020043979, US 20020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020120020120020120020120043979, US 200200200200200200200200200200200200200200200200200200200200200200200200200200200, WO2012020327, WO2012163471, WO2013094620, WO2013107487, WO2013174471, WO2014007565, WO2014008982, WO2014023377, WO2014024131, WO2014031977, WO2014038456, WO 2014112450.
Figure BDA0002502234840000781
Figure BDA0002502234840000791
Figure BDA0002502234840000801
Figure BDA0002502234840000811
Figure BDA0002502234840000821
f)HBL:
Hole Blocking Layers (HBLs) may be used to reduce the number of holes and/or excitons that leave the emissive layer. The presence of such a barrier layer in a device may result in substantially higher efficiency and/or longer lifetime compared to a similar device lacking a barrier layer. In addition, blocking layers can be used to limit the emission to the desired area of the OLED. In some embodiments, the HBL material has a lower HOMO (farther from the vacuum level) and/or higher triplet energy than the emitter closest to the HBL interface. In some embodiments, the HBL material has a lower HOMO (farther from the vacuum level) and/or higher triplet energy than one or more of the hosts closest to the HBL interface.
In one aspect, the compound used in the HBL contains the same molecule or the same functional group as used for the host described above.
In another aspect, the compound used in HBL contains in the molecule at least one of the following groups:
Figure BDA0002502234840000831
wherein k is an integer from 1 to 20; l is101Is another ligand, and k' is an integer of 1 to 3.
g)ETL:
The Electron Transport Layer (ETL) may include a material capable of transporting electrons. The electron transport layer may be intrinsic (undoped) or doped. Doping may be used to enhance conductivity. Examples of the ETL material are not particularly limited, and any metal complex or organic compound may be used as long as it is generally used to transport electrons.
In one aspect, the compound used in the ETL contains in the molecule at least one of the following groups:
Figure BDA0002502234840000832
wherein R is101Selected from the group consisting of: hydrogen, deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, aralkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, thio, sulfinyl, sulfonyl, phosphino, and combinations thereof, which when aryl or heteroaryl has a similar definition to Ar described above. Ar (Ar)1To Ar3Have similar definitions as Ar mentioned above. k is an integer of 1 to 20. X101To X108Selected from C (including CH) or N.
In another aspect, the metal complex used in the ETL contains (but is not limited to) the following general formula:
Figure BDA0002502234840000841
wherein (O-N) or (N-N) is a bidentate ligand having a metal coordinated to atom O, N or N, N; l is101Is another ligand; k' is an integer value from 1 to the maximum number of ligands that can be attached to the metal.
Non-limiting examples of ETL materials that can be used in an OLED in combination with the materials disclosed herein, along with references disclosing those materials, are exemplified as follows: CN103508940, EP01602648, EP01734038, EP01956007, JP2004-022334, JP2005149918, JP2005-268199, KR0117693, KR20130108183, US20040036077, US20070104977, US2007018155, US20090101870, US20090115316, US20090140637, US 2009017959554, US2009218940, US2010108990, US2011156017, US2011210320, US2012193612, US2012214993, US 20140142014014925, US 201401492014927, US 2014028450284580, US 5666612, US 1508431, WO 200306093060979256, WO2007111263, WO2009148269, WO2010067894, WO2010072300, WO 201107070, WO 105373, WO 201303017, WO 201314545477, WO 2014545667, WO 201104376, WO2014104535, WO 2014535,
Figure BDA0002502234840000842
Figure BDA0002502234840000851
Figure BDA0002502234840000861
h) charge Generation Layer (CGL)
In tandem or stacked OLEDs, CGL plays a fundamental role in performance, consisting of an n-doped layer and a p-doped layer for injecting electrons and holes, respectively. Electrons and holes are supplied by the CGL and the electrodes. Electrons and holes consumed in the CGL are refilled by electrons and holes injected from the cathode and anode, respectively; subsequently, the bipolar current gradually reaches a steady state. Typical CGL materials include n and p conductivity dopants used in the transport layer.
In any of the above-mentioned compounds used in each layer of the OLED device, the hydrogen atoms may be partially or fully deuterated. Thus, any of the specifically listed substituents, such as (but not limited to) methyl, phenyl, pyridyl, and the like, can be in their non-deuterated, partially deuterated, and fully deuterated forms. Similarly, substituent classes (such as, but not limited to, alkyl, aryl, cycloalkyl, heteroaryl, etc.) can also be non-deuterated, partially deuterated, and fully deuterated forms thereof.
It should be understood that the various embodiments described herein are by way of example only and are not intended to limit the scope of the invention. For example, many of the materials and structures described herein may be substituted with other materials and structures without departing from the spirit of the invention. The invention as claimed may thus comprise variations of the specific examples and preferred embodiments described herein, as will be apparent to those skilled in the art. It should be understood that various theories as to why the invention works are not intended to be limiting.
Synthesis of materials
Synthesis of 7-bromo-3, 4-dihydronaphthalen-1-yl trifluoromethanesulfonate
Figure BDA0002502234840000871
7-bromo-3, 4-dihydronaphthalen-1 (2H) -one (45.0g, 200mmol) and 1,1, 1-trifluoro-N-phenyl-N- ((trifluoromethyl) sulfonyl) methanesulfonamide (79.0g, 220mmol) were dissolved in anhydrous THF (1000 ml). It was cooled to-78 ℃ and toluene (314ml, 220mmol) containing a 15% solution of potassium bis (trimethylsilyl) amide was added. The reaction mixture was stirred at-78 ℃ for 3 hours. The reaction mixture was allowed to stand overnight under nitrogen to warm to room temperature. After all of the 7-bromo-3, 4-dihydronaphthalen-1 (2H) -one was consumed, the reaction was quenched by the addition of water (50 ml). The crude material was then purified by flash chromatography using a mixture of heptane and dichloromethane in a standard silica solid phase to give 7-bromo-3, 4-dihydronaphthalen-1-yl trifluoromethanesulfonate as a pale yellow oil (68.9g, 193mmol, 96% yield).
Synthesis of 6-bromo-4- (3-chlorophenyl) -1, 2-dihydronaphthalene
Figure BDA0002502234840000872
7-bromo-3, 4-dihydronaphthalen-1-yl trifluoromethanesulfonate (68.9g, 193mmol), (3-chlorophenyl) boronic acid (30.2g, 193mmol) and Cs2CO3(157g, 482mmol) was dissolved in deoxygenated dioxane (1000 ml). Adding [1,1' -bis (diphenylphosphino) ferrocene]A complex of palladium (II) dichloride and dichloromethane (7.86g, 9.65mmol) and the reaction mixture was stirred at room temperature under nitrogen overnight (about 16 hours). (3-chlorophenyl) boronic acid (2.00g, 12.8mmol) and [1,1' -bis (diphenylphosphine) were addedYl) ferrocene]A complex of palladium (II) dichloride and dichloromethane (3.00g, 3.67mmol) and the reaction mixture was stirred at room temperature under nitrogen overnight. The reaction mixture was then heated to 50 ℃ for 4 hours. The solvent was evaporated and the crude material was subsequently purified by flash chromatography using heptane in a standard silica solid phase to give 6-bromo-4- (3-chlorophenyl) -1, 2-dihydronaphthalene (53.9g, 169mmol, 87% yield) as a colorless oil.
Synthesis of 7-bromo-1- (3-chlorophenyl) naphthalene
Figure BDA0002502234840000873
6-bromo-4- (3-chlorophenyl) -1, 2-dihydronaphthalene (53.9g, 169mmol) was dissolved in DCM (1000 ml). 2, 3-dichloro-5, 6-dicyanobenzoquinone (DDQ) (57.4g, 253mmol) was added at room temperature and the reaction mixture was stirred at 50 ℃ overnight under nitrogen. The reaction mixture was cooled to room temperature and NaHCO was added3(saturated aqueous solution, 800ml) and DCM (300 ml). The organic layer was separated and the aqueous layer was washed with DCM (500 ml). The combined organic layers were over MgSO4The volatiles were dried and evaporated. The resulting crude brown oil was purified by flash chromatography using heptane in a standard silica solid phase to give 7-bromo-1- (3-chlorophenyl) naphthalene (41.0g, 129mmol, 77% yield) as a pale yellow oil.
Synthesis of 4,4,5, 5-tetramethyl-2- (3- (7- (4,4,5, 5-tetramethyl-1, 3, 2-dioxaborolan-2-yl) naphthalen-1-yl) phenyl) -1,3, 2-dioxaborolan
Figure BDA0002502234840000881
7-bromo-1- (3-chlorophenyl) naphthalene (6.00g, 18.9mmol), bis (pinacolato) diboron (19.19g, 75.6mmol), potassium acetate (9.27g, 94.5mmol) and dicyclohexyl (2',6' -dimethoxy- [1,1' -biphenyl ] -2-yl) phosphine (SPhos) (1.55g, 3.78mmol) were dissolved in anhydrous dioxane (120mL) in a 500mL 3-necked round bottom flask equipped with a reflux condenser. The mixture was sparged with nitrogen for 15 minutes, followed by the addition of tris (dibenzylideneacetone) dipalladium (0) (1.73g, 1.89mmol) and additional degassing for an additional 15 minutes. Subsequently, the reaction mixture was stirred at 100 ℃ for 18 hours. After cooling to room temperature, the reaction mixture was filtered through a celite cartridge and the volatiles were removed in vacuo. The resulting dark brown crude mixture was extracted with ethyl acetate (100 mL. times.2) and washed with brine (100 mL). The combined organic phases were dried over magnesium sulfate and the solvent was removed in vacuo. The resulting crude mixture was purified by flash chromatography using a mixture of isohexane and ethyl acetate in a standard silica solid phase to give a yellow solid (4.18g, 9.26mmol, 49%).
Synthesis of 4- (tert-butyl) -2- (3- (7- (4- (tert-butyl) pyridin-2-yl) naphthalen-1-yl) phenyl) pyridine
Figure BDA0002502234840000882
4,4,5, 5-tetramethyl-2- [3- [7- (4,4,5, 5-tetramethyl-1, 3, 2-dioxaboropent-2-yl) -1-naphthyl ] phenyl ] -1,3, 2-dioxaborolan (3.50g, 7.67mmol), 4-tert-butyl-2-chloro-pyridine (5.21g, 30.7mmol), tripotassium phosphate (6.51g, 30.7mmol) were dissolved in anhydrous N, N-dimethylformamide (106mL) in a 500mL 3-neck round bottom flask equipped with a reflux condenser. The mixture was sparged with nitrogen for 15 minutes, followed by the addition of tetrakis (triphenylphosphine) palladium (0) (1.42g, 1.23mmol) and additional degassing for an additional 15 minutes. Subsequently, the reaction mixture was stirred at 100 ℃ for 18 hours. After cooling to room temperature, the reaction mixture was filtered through a celite cartridge and the volatiles were removed in vacuo. The resulting dark brown crude mixture was extracted with ethyl acetate (100 mL. times.2) and washed with brine (100 mL). The combined organic phases were dried over magnesium sulfate and the solvent was removed in vacuo. The resulting crude mixture was purified by flash chromatography using a mixture of isohexane and acetone in a standard silica solid phase, followed by wet milling with isohexane to give a white solid (2.32g, 4.91mmol, 64%).
Synthesis of example Compound I-A34 of the invention
Figure BDA0002502234840000891
A mixture of 4- (tert-butyl) -2- (3- (7- (4- (tert-butyl) pyridin-2-yl) naphthalen-1-yl) phenyl) pyridine (2.7g, 5.74mmol) and dichloro (1, 5-cyclooctadiene) palladium (II) (2.15g, 5.74mmol) in 1, 2-dichlorobenzene (10mL) was sparged with nitrogen for 15 minutes. After refluxing for 6 days, the volatiles were removed under reduced pressure. The crude residue was purified by flash chromatography using a mixture of ethyl acetate and dichloromethane in a standard silica solid phase followed by wet milling with methanol to give a brown solid (0.25g, 0.38mmol, 6.5%).
TABLE 1
Figure BDA0002502234840000892
Table 1 above provides a table performed to determine the HOMO/LUMO levels, HOMO-LUMO energy gaps, and lowest triplet (T) for various compounds1) The result of the DFT calculation of the energy of the excited state. Data was collected using the program Gaussian 16. The B3LYP function and the CEP-31G basis set were used to optimize the geometry. The excited state energy is calculated by TDDFT with optimized ground state geometry. The THF solvent was simulated using a self-consistent reaction field to further improve agreement with the experiment. Illustrative examples of the invention T of Compound I-A1, Compound I-A34, Compound I-A501, Compound II-A1, Compound XXXII-A1, and Compound XXXV-A11The energies were calculated as 713, 706, 732, 825, 718 and 710 nm. Due to the conjugated moiety of phenyl-naphthalene, all compounds exhibit phosphorescence in the deep red to Near Infrared (NIR) region.
The Photoluminescence (PL) spectra of example compounds I-A34 of the invention obtained in 2-methyl THF solution at room temperature are shown in FIG. 3. PL intensity was normalized to the maximum of the first emission peak. The maximum emission peak and the second emission peak of the present invention instantiation compound I-A34 are 658nm and 723 nm. Due to the highly rigid and conjugated phenyl-naphthalene moiety, the present examples show deep red to near infrared emission. When the present exemplary compounds are used as emitting dopants in organic electroluminescent devices, it is expected that deep red to near infrared light will be emitted with good device performance.
The calculations obtained using the set of DFT functions and the base set identified above are theoretical. Computing the combination protocol (gauss 09 with B3LYP and CEP-31G protocols as used herein) relies on the following assumptions: the electronic effects are additive and therefore the Complete Basis Set (CBS) limit can be extrapolated using larger basis sets. However, when the objective of the study is to understand the HOMO, LUMO, S of a series of structurally related compounds1、T1The additive effect is expected to be similar when the bond dissociation energy, etc. varies. Thus, while the absolute error using B3LYP may be significant compared to other calculation methods, HOMO, LUMO, S calculated using the B3LYP protocol are expected1、T1And the relative difference between the bond dissociation energy values are expected to reproduce the experiment well. See, e.g., flood et al, material chemistry (chem. mater.)2016,28, 5791-. Furthermore, with respect to iridium or platinum complexes suitable for use in the OLED field, the data obtained from the DFT calculations closely correlates with the actual experimental data. See tawasie et al, journal of materials chemistry (j. mater. chem.)2012,22,6419-29,6422 (table 3) (showing DFT calculations closely related to actual data for various emission complexes); morelalo, G.R. (Morello, G.R.), journal of molecular models (j.mol. model.)2017,23:174 (studying various sets of DFT functions and basis sets and concluding that the combination of B3LYP and CEP-31G is particularly accurate for emissive complexes).

Claims (20)

1. A compound comprising a first ligand L of formula 1A
Figure FDA0002502234830000011
Wherein,
each X1To X10Is C or N;
x in the same ring as N1To X10The maximum number of (a) is three;
RAand RBEach represents mono-to maximum permissible substitution or no substitution;
LAcomplexing with a metal M;
each RAAnd RBIndependently hydrogen or a substituent selected from the group consisting of: deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, aralkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, thio, sulfinyl, sulfonyl, phosphino, borinyl, and combinations thereof;
m may coordinate to other ligands;
the ligand LAMay be linked to other ligands to form tridentate, tetradentate, pentadentate or hexadentate ligands; and is
Any two substituents may be joined or fused together to form a ring.
2. The compound of claim 1, wherein each RAAnd RBIndependently hydrogen or a substituent selected from the group consisting of: deuterium, fluorine, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile, thio, oxyboronyl, and combinations thereof.
3. The compound of claim 1, wherein M is selected from the group consisting of: ru, Os, Ir, Pd, Pt, Cu, Ag, and Au.
4. The compound of claim 1, wherein the first ligand LAWith one or two other ligands to form a tridentate or tetradentate ligand.
5. The compound of claim 1, wherein RAAnd RBIs a 5-or 6-membered heterocyclic ring.
6. The compound of claim 1, wherein RAAnd RBIs selected from the group consisting of: pyridine, pyrimidine, triazine, imidazole, pyrazole, triazole and N-heterocyclic carbenes.
7. The compound of claim 1, wherein X1To X10Is N.
8. The compound of claim 1, wherein each X1To X10Is C.
9. The compound of claim 1, wherein two R' sAThe substituents are joined together to form a six-membered carbocyclic or heterocyclic ring.
10. The compound of claim 1, wherein two or more RBThe substituents are joined together to form a six-membered carbocyclic or heterocyclic ring or ring.
11. The compound of claim 1, wherein the compound has formula 2
Figure FDA0002502234830000021
Wherein,
m is Pd or Pt;
ring C and ring D are each independently a 5-or 6-membered carbocyclic or heterocyclic ring;
Z1and Z2Each independently is C or N;
W1and W2Each independently is C or N;
RCand RDEach independently represents mono-to maximum permissible substitution or no substitution;
L1、L2and L3Each independently is 1 atom or 2 atom linker, or a direct bond;
m, n and p are each independently 0 or 1;
m + n + p is 2 or 3;
each RCAnd RDIndependently hydrogen or a substituent selected from the group consisting of: deuterium, fluoro, alkyl, cycloalkyl, heteroalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile, thio, oxyboronyl, and combinations thereof; and is
Any two substituents may be joined or fused together to form a ring.
12. The compound of claim 11, wherein p ═ 0, and L1And L2Each independently selected from the group consisting of: direct bond, O, S, CRR ', SiRR', BR, and NR; and is
Wherein each R and R' is independently hydrogen or a substituent selected from the group consisting of: deuterium, fluorine, alkyl, cycloalkyl, heteroalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile, thio, oxyboronyl, and combinations thereof.
13. The compound of claim 1, wherein the compound is selected from the group consisting of:
Figure FDA0002502234830000031
Figure FDA0002502234830000041
Figure FDA0002502234830000051
Figure FDA0002502234830000061
Figure FDA0002502234830000071
wherein,
A1to A10Each independently is C or N, such that the maximum number of N atoms in the same ring is 3;
X11to X14And X1To X10Have the same definition;
REand RFAnd RCAnd RDHave the same definition;
L4represents a linker;
RXand RYEach independently selected from the group consisting of: alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, aryl, heteroaryl, and combinations thereof; and is
Any two substituents may be joined or fused together to form a ring.
14. The compound of claim 1, wherein the compound is selected from the group consisting of:
Figure FDA0002502234830000081
Figure FDA0002502234830000091
Figure FDA0002502234830000101
Figure FDA0002502234830000111
Figure FDA0002502234830000121
wherein I is an integer from 1 to 2000, and R for each of formulas I to LVIII1、R2、R3、R4、Y1And Y2The definition is as follows:
Figure FDA0002502234830000122
Figure FDA0002502234830000131
Figure FDA0002502234830000141
Figure FDA0002502234830000151
Figure FDA0002502234830000161
Figure FDA0002502234830000171
Figure FDA0002502234830000181
Figure FDA0002502234830000191
Figure FDA0002502234830000201
Figure FDA0002502234830000211
Figure FDA0002502234830000221
Figure FDA0002502234830000231
Figure FDA0002502234830000241
Figure FDA0002502234830000251
Figure FDA0002502234830000261
Figure FDA0002502234830000271
Figure FDA0002502234830000281
Figure FDA0002502234830000291
Figure FDA0002502234830000301
Figure FDA0002502234830000311
Figure FDA0002502234830000321
Figure FDA0002502234830000331
Figure FDA0002502234830000341
wherein R isA1To RA53Has the following structure:
Figure FDA0002502234830000342
Figure FDA0002502234830000343
Figure FDA0002502234830000351
Figure FDA0002502234830000352
and is
Wherein R isB1To RB46Has the following structure:
Figure FDA0002502234830000353
Figure FDA0002502234830000354
Figure FDA0002502234830000361
and is
Wherein R isC1To RC292Has the following structure:
Figure FDA0002502234830000362
Figure FDA0002502234830000363
Figure FDA0002502234830000371
Figure FDA0002502234830000381
Figure FDA0002502234830000391
Figure FDA0002502234830000401
Figure FDA0002502234830000411
Figure FDA0002502234830000421
15. the compound of claim 14, wherein the compound is selected from the group consisting of:
Figure FDA0002502234830000431
Figure FDA0002502234830000441
Figure FDA0002502234830000451
Figure FDA0002502234830000461
16. an Organic Light Emitting Device (OLED), comprising:
an anode;
a cathode; and an organic layer disposed between the anode and the cathode, comprising a metal oxide layer comprising formula 1
Figure FDA0002502234830000471
First ligand L ofAA compound of (1);
wherein,
each X1To X10Is C or N;
x in the same ring as N1To X10The maximum number of (a) is three;
RAand RBEach represents mono-to maximum permissible substitution or no substitution;
LAcomplexing with a metal M;
each RAAnd RBIndependently hydrogen or a substituent selected from the group consisting of: deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, aralkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, thio, sulfinyl, sulfonyl, phosphino, borinyl, and combinations thereof;
m may coordinate to other ligands;
the ligand LAMay be linked to other ligands to form tridentate, tetradentate, pentadentate or hexadentate ligands; and is
Any two substituents may be joined or fused together to form a ring.
17. The OLED of claim 16, wherein the organic layer further comprises a host, wherein host comprises at least one chemical group selected from the group consisting of: triphenylene, carbazole, indolocarbazole, dibenzothiophene, dibenzofuran, dibenzoselenophene, 5, 9-dioxa-13 b-boronaphtho [3,2,1-de ] anthracene, aza-triphenylene, aza-carbazole, aza-indolocarbazole, aza-dibenzothiophene, aza-dibenzofuran, aza-dibenzoselenophene, and aza- (5, 9-dioxa-13 b-boronaphtho [3,2,1-de ] anthracene).
18. The OLED of claim 17 wherein the host is selected from the group consisting of:
Figure FDA0002502234830000472
Figure FDA0002502234830000481
Figure FDA0002502234830000491
Figure FDA0002502234830000492
and combinations thereof.
19. A consumer product comprising an organic light emitting device, OLED, said OLED comprising:
an anode;
a cathode; and
an organic layer disposed between the anode and the cathode comprising a material comprising formula 1
Figure FDA0002502234830000493
First ligand L ofAA compound of (1);
wherein,
each X1To X10Is C or N;
x in the same ring as N1To X10The maximum number of (a) is three;
RAand RBEach represents mono-to maximum permissible substitution or no substitution;
LAcomplexing with a metal M;
each RAAnd RBIndependently hydrogen or a substituent selected from the group consisting of: deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, aralkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, thio, sulfinyl, sulfonyl, phosphino, borinyl, and combinations thereof;
m may coordinate to other ligands;
the ligand LAMay be linked to other ligands to form tridentate, tetradentate, pentadentate or hexadentate ligands; and is
Any two substituents may be joined or fused together to form a ring.
20. A formulation comprising the compound of claim 1.
CN202010435881.5A 2019-05-21 2020-05-21 Organic electroluminescent material and device Pending CN111978352A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201962850800P 2019-05-21 2019-05-21
US62/850,800 2019-05-21
US16/867,014 US11634445B2 (en) 2019-05-21 2020-05-05 Organic electroluminescent materials and devices
US16/867,014 2020-05-05

Publications (1)

Publication Number Publication Date
CN111978352A true CN111978352A (en) 2020-11-24

Family

ID=73442185

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010435881.5A Pending CN111978352A (en) 2019-05-21 2020-05-21 Organic electroluminescent material and device

Country Status (2)

Country Link
JP (1) JP2020189836A (en)
CN (1) CN111978352A (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050260445A1 (en) * 2004-05-18 2005-11-24 Robert Walters OLEDs utilizing macrocyclic ligand systems
US20050260444A1 (en) * 2004-05-18 2005-11-24 Forrest Stephen R OLEDs utilizing macrocyclic ligand systems
US20080100208A1 (en) * 2006-11-01 2008-05-01 Samsung Electronics Co., Ltd. Organic light-emitting compound, organic light-emitting device including the compound, and method of manufacturing the organic light-emitting device
CN105658606A (en) * 2013-10-29 2016-06-08 捷恩智株式会社 Anthracene compound; light-emitting-layer material; and organic electroluminescent element, display device, and illumination device using same
US20160359121A1 (en) * 2015-06-03 2016-12-08 Samsung Display Co., Ltd. Organic light-emitting display device
US20170025619A1 (en) * 2013-07-01 2017-01-26 Samsung Display Co., Ltd. Organic light-emitting device
CN108352449A (en) * 2016-10-18 2018-07-31 株式会社Lg化学 Organic luminescent device

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4773109B2 (en) * 2005-02-28 2011-09-14 高砂香料工業株式会社 Platinum complex and light emitting device
JP2007080593A (en) * 2005-09-12 2007-03-29 Fujifilm Corp Electrochemical light-emitting element
DE102008063470A1 (en) * 2008-12-17 2010-07-01 Merck Patent Gmbh Organic electroluminescent device
DE102009014513A1 (en) * 2009-03-23 2010-09-30 Merck Patent Gmbh Organic electroluminescent device
WO2012066445A1 (en) * 2010-11-17 2012-05-24 Koninklijke Philips Electronics N.V. Seamless faceplate assembly for keypad device
TWI561527B (en) * 2011-07-25 2016-12-11 Universal Display Corp Tetradentate platinum complexes
JP6271434B2 (en) * 2011-10-06 2018-01-31 メルク パテント ゲーエムベーハー Organic electroluminescence device
JP6804823B2 (en) * 2013-10-14 2020-12-23 アリゾナ・ボード・オブ・リージェンツ・オン・ビハーフ・オブ・アリゾナ・ステイト・ユニバーシティーArizona Board of Regents on behalf of Arizona State University Platinum complex and device
US10056567B2 (en) * 2014-02-28 2018-08-21 Arizona Board Of Regents On Behalf Of Arizona State University Chiral metal complexes as emitters for organic polarized electroluminescent devices
US10862054B2 (en) * 2016-06-20 2020-12-08 Universal Display Corporation Organic electroluminescent materials and devices

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050260445A1 (en) * 2004-05-18 2005-11-24 Robert Walters OLEDs utilizing macrocyclic ligand systems
US20050260444A1 (en) * 2004-05-18 2005-11-24 Forrest Stephen R OLEDs utilizing macrocyclic ligand systems
US20080100208A1 (en) * 2006-11-01 2008-05-01 Samsung Electronics Co., Ltd. Organic light-emitting compound, organic light-emitting device including the compound, and method of manufacturing the organic light-emitting device
US20170025619A1 (en) * 2013-07-01 2017-01-26 Samsung Display Co., Ltd. Organic light-emitting device
CN105658606A (en) * 2013-10-29 2016-06-08 捷恩智株式会社 Anthracene compound; light-emitting-layer material; and organic electroluminescent element, display device, and illumination device using same
US20160359121A1 (en) * 2015-06-03 2016-12-08 Samsung Display Co., Ltd. Organic light-emitting display device
CN108352449A (en) * 2016-10-18 2018-07-31 株式会社Lg化学 Organic luminescent device

Also Published As

Publication number Publication date
JP2020189836A (en) 2020-11-26

Similar Documents

Publication Publication Date Title
EP3398953B1 (en) Organic electroluminescent materials and devices
CN118271293A (en) Organic electroluminescent material and device
KR20240058828A (en) Organic electroluminescent materials and devices
KR20160119713A (en) Organic electroluminescent materials and devices
KR20160056844A (en) Organic electroluminescent materials and devices
KR20170142949A (en) Organic electroluminescent materials and devices
KR20170039602A (en) Organic electroluminescent materials and devices
EP3305796B1 (en) Organic electroluminescent materials and devices
KR102698682B1 (en) Organic electroluminescent materials and devices
CN112442055A (en) Organic electroluminescent material and device
CN110713492A (en) Organic electroluminescent material and device
KR20190120082A (en) Host materials for electroluminescent devices
CN111138495A (en) Organic electroluminescent material and device
CN110903324A (en) Organic electroluminescent material and device
CN112625066A (en) Organic electroluminescent material and device
KR20210016299A (en) Organic electroluminescent materials and devices
CN112390828A (en) Organic electroluminescent material and device
CN110563768B (en) Organic electroluminescent material and device
CN112794814A (en) Organic electroluminescent material and device
CN111925397A (en) Organic electroluminescent material and device
CN112279875A (en) Organic electroluminescent material and device
EP2874192B1 (en) Organic eletroluminescent materials and devices
CN115477676A (en) Organic electroluminescent material and device
CN114315867A (en) Fast phosphors using HP2H ligand
CN112390827A (en) Organic electroluminescent material and device

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination